ugars, particularly fructose-containing sugars, have been implicated as an important driver in the rise in incidence of type 2 diabetes.
risk ratios (RRs) using random effects meta-analyses. The overall quality of the evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system.
Data sources and searches
We searched MEDLINE, Embase, CINAHL and the Cochrane Library databases through June 2016. The search strategy is presented in supplementary Table 1 (Appendix 1, available at www. cmaj.ca/lookup/suppl/doi:10.1503/cmaj.160706/-/DC1). The search was restricted to human studies without language restrictions. Manual searches of the reference lists of included studies supplemented electronic searches.
Study selection
We included prospective cohort studies that assessed intake of fructose-containing sugars (total sugars, fructose, sucrose, highfructose corn syrup or added sugars) and incident type 2 diabetes in participants who did not have diabetes.
Data extraction
Two reviewers (C.T. and R.T.) independently extracted relevant data from included studies. The main outcome was type 2 diabetes risk expressed as risk ratios (RRs) with 95% confidence intervals (CI). Authors were contacted for missing data.
Risk of bias
The Newcastle-Ottawa Scale (NOS) was used to assess the risk of bias in included studies, where up to 9 points were awarded based on cohort selection, comparability (adjustments) and ascertainment of the outcome. 8 Owing to concerns regarding the use of cut-off scores, 6 we did not use our prespecified cut-off score for NOS. 9 Differences were reconciled by consensus.
Grading of the evidence
The quality and strength of the evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Included observational studies started at low-quality evidence by default and then were downgraded or upgraded based on prespecified criteria. Criteria to downgrade included study limitations (weight of studies showed risk of bias by NOS), inconsistency (substantial unexplained interstudy heterogeneity, I
2 > 50% and p < 0.10), indirectness (presence of factors relating to the population, exposures and outcomes that limit generalizability), imprecision (95% CIs were wide or crossed a minimally important difference of 10% [RR 0.9-1.1]) and publication bias (significant evidence of small-study effects). Criteria to upgrade included a large size effect (RR > 2 or RR < 0.5 in the absence of plausible confounders), a dose-response gradient and attenuation by plausible confounding effects.
Statistical analysis
To obtain summary estimates, we natural log-transformed and pooled the RRs using the generic inverse variance method with random-effects models. We used RRs comparing extreme quanRecords identified through database searches n = 8381
Excluded n = 8275
• Duplicate records n = 2305 • Reviews/meta-analyses/editorials/commentaries/letters/
• Observational studies proceedings/practice guidelines/reports n = 2000 n = 1306 • Animal or in vitro studies n = 972 • Studies with irrelevant outcomes n = 864 • Intervention trials n = 828
Full-text articles assessed for eligibility n = 106
Excluded n = 97
• Reviews/meta-analyses/editorials/ commentaries/letters/
• Studies with no assessment of fructose-containing sugar exposure n = 24
• Studies with irrelevant outcomes n = 19
• Observational studies n = 10 • Duplicate records n = 5
• Intervention trials n = 3
• Not retrievable n = 3
• Overlapping data n = 1
Studies included in the meta-analysis n = 9 (15 cohorts) Records identified through manual search n = 4
proceedings/practice guidelines/reports n = 32 tiles and scaled RRs per 100 g/d for total sugars, 50 g/d for fructose and 50 g/d for sucrose to standardize the doses based on estimated average intakes in Canada. 23 Heterogeneity was assessed (Cochran Q statistic) and quantified (I 2 statistic). If I 2 was greater than or equal to 50%, we interpreted this as indicating substantial heterogeneity. 6, 16 We investigated possible sources of heterogeneity. To assess whether any single study exerted an undue influence on the summary estimates, we performed sensitivity analyses by systematically removing each study with recalculation of the summary estimates. We performed additional sensitivity analyses by restricting pooled analyses to studies using validated measures of sugars intake to assess any influence of how the exposures were assessed. Prespecified subgroup analyses were done by sex, follow-up, NOS and individual domains of NOS using meta-regression analyses. Linear and nonlinear doseresponse analyses were assessed by using generalized least squares trend (GLST) estimation models and spline curve modelling (MKSPLINE procedure). If 10 or more cohort comparisons were available, we investigated publication bias by visual inspection of funnel plots and using the Begg and Egger tests. Data were analyzed using Review Manager (RevMan) version 5.2 (The Nordic Cochrane Centre) and Stata version 12 (StataCorp). Figure 1 shows the flow of the literature search. Out of 8381 reports, we included 9 reports of 15 cohort studies involving 251 261 unique participants and 16 416 cases of type 2 diabetes:
Results
24-32 12 cohort comparisons (n = 105 846, 13 727 cases) for total sugars, 6 cohort comparisons (n = 107 972, 3833 cases) for fructose and 8 cohort comparisons (n = 192 332, 4535 cases) for sucrose. There were no cohort comparisons available for high-fructose corn syrup or added sugars. Table 1 shows the characteristics of the included studies. Participants were from 11 countries and had a median age of Funding sources did not include industry funding. Thirteen studies reported funding from agency alone, whereas the other 2 studies did not report funding sources.
Supplementary Table 2 (Appendix 1) shows the statistical adjustments performed in the included studies. All studies adjusted for the prespecified primary confounding variable (age) and adjusted for at least 4 of 5 secondary confounding variables (markers of overweight/obesity, family history of diabetes, energy intake, physical activity, sex).
Supplementary Table 3 (Appendix 1) shows the NOS scores for the included studies. Although several studies lost points for selection and outcome assessment, there was no evidence of serious risk of bias across the included studies.
Visual inspection of funnel plots (Supplementary Figure 18 , Appendix 1), and formal testing with the Begg (p = 0.7) and Egger tests (p = 0.4) did not show evidence of publication bias for total sugars. Publication bias was not assessed for fructose and sucrose because there were less than 10 cohort comparisons.
Supplementary Table 4 (Appendix 1) shows a summary of the GRADE assessments for the association of total sugars, fructose and sucrose intake with incident type 2 diabetes. The evidence for a lack of harm was rated as very low quality for total sugars and fructose because of downgrades for serious inconsistency and imprecision, and low quality for sucrose because of a downgrade for serious imprecision and an upgrade for a significant inverse dose-response gradient. compared the highest and the lowest levels of intake. Risk ratio per 100 g/d intake was 0.92 (95% CI 0.77-1.08), with evidence of substantial heterogeneity (I 2 = 79%, p < 0.001). Figure 3 and supplementary Figure 2 (Appendix 1) show the relation between fructose intake and incident type 2 diabetes. We found no association (RR 1.04, 95% CI 0.84-1.29) with evidence of substantial heterogeneity among studies (I 2 = 71%, p < 0.01) when we compared the highest and the lowest levels of intake. Risk ratio per 50 g/d intake was 1.09 (95% CI 0.73-1.63), with evidence of substantial heterogeneity (I 2 = 75%, p < 0.01). Figure 4 and supplementary Figure 3 
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Additional analyses
The systematic removal of each study did not modify the lack of an association for total sugars or fructose. However, the removal of the study by Hodge and colleagues 27 (I 2 = 9%, p = 0.4) in the analysis of total sugars and the study by Ahmadi-Abhari and colleagues 32 (I 2 = 40%, p = 0.2) in the fructose analysis did explain away most of the evidence of heterogeneity. The inverse association for sucrose was lost through the systematic removal of the studies by Colditz and colleagues 24 Restricting analyses to studies in which sugars were assessed using validated measures neither modified the associations nor the evidence of heterogeneity for total sugars, fructose or sucrose (supplementary Figures 4-6, Appendix 1) . Supplementary Figures 7-12 (Appendix 1) provide the a priori subgroup analyses. There was no evidence of effect modification for the associations of total sugars, fructose and sucrose with incident type 2 diabetes in a priori subgroup analyses. Any evidence of significant interstudy heterogeneity was not explained by a priori subgroup analyses.
There was no evidence of a dose-response gradient for total sugars or fructose using GLST estimation (supplementary Figures 13 and 14, Appendix 1) . No dose-response gradient or dose thresholds for fructose was seen using the MKSPLINE procedure (supplementary Figure 15 , Appendix 1), whereas total sugars could not be modelled because of insufficient data. Results of GLST estimation for sucrose showed evidence of a significant inverse relationship with incident type 2 diabetes per 25 g/d intake (RR 0.92, 95% CI 0.85-0.99, p = 0.03) (supplementary Figure  16 , Appendix 1), but this relation was not seen for results using the MKSPLINE procedure (supplementary Figure 17 , Appendix 1).
Interpretation
We conducted a systematic review and meta-analysis of prospective cohort studies of the relation between intake of sugars and incident type 2 diabetes. Pooled analyses showed that intakes of total sugars and fructose were not associated with type 2 diabetes, whereas intake of sucrose was associated with an 11% decrease in type 2 diabetes.
Our results do not support a hypothesis that the positive association seen between sugar-sweetened beverages and diabetes is mediated by the fructose-containing sugars they contain. Systematic reviews and meta-analyses have shown that sugar-sweetened beverages are associated with an increase in the risk of type 2 diabetes. 4, 5, 33 Our pooled analyses failed to show a similar increase despite the inclusion of data from mostly the same set of cohorts.
The lack of an adverse association is difficult to reconcile with the biological mechanisms and ecological observations linking fructose- containing sugars to type 2 diabetes. [34] [35] [36] [37] [38] [39] It is also difficult to reconcile with our earlier systematic review and meta-analysis showing a positive association between fructose intake and gout, 9 given the emerging links between uric acid and diabetes. 37 One possible explanation for the lack of agreement is residual confounding from reverse causality. People at high risk of type 2 diabetes may avoid sugars as a preventive strategy, which decreases the risk associated with intake of total sugars, fructose or sucrose. Another explanation may relate to the increased intake of healthier food sources of sugars other than sugar-sweetened beverages, which themselves show null or protective associations with type 2 diabetes.
Although sugar-sweetened beverages are sources of most fructose-containing sugars in Canadian and American diets, other sources contribute meaningfully to overall intake 23, 40 (e.g., grains and grain products, fruit and fruit products, and dairy and dairy products). 23, 40 Many of these other food sources, which tend to be sweetened with sucrose, have either shown no association (e.g., cakes and cookies, 41 and sherbert 42 ) or a protective association (e.g., whole-grain cereals, fruit, yogurt and even ice cream [42] [43] [44] ) with type 2 diabetes (Appendix 2, available at www.cmaj.ca/ lookup/suppl/doi:10.1503/cmaj.160706/-/DC1). An inverse doseresponse gradient, similar to that for sucrose, has even been found for whole-grain cereals, fruit and yogurt. [42] [43] [44] Taken together, lack of an adverse association between intakes of total sugars, fructose or sucrose and diabetes may reflect important contributions from these other food sources.
In the absence of a particular adverse association between fructose-containing sugars and incident diabetes, one must consider alternative explanations for the observed association between sugar-sweetened beverages and diabetes. One explanation may relate to uncompensated energy. Systematic reviews and meta-analyses of controlled feeding trials [45] [46] [47] [48] [49] [50] [51] have shown that the adverse effect of sugars on cardiometabolic risk factors is mediated by excess energy, with a signal for harm largely restricted to comparisons in which sugars supplement background diets with excess energy. It is possible that the food form of sugar-sweetened beverages promotes the excess energy intake. Evidence from systematic reviews and meta-analyses of acute preload trials have shown that sugars in liquid form elicit a weaker satiety response and are less compensated by a decrease in energy intake at subsequent meals than sugars in solid form, 52 a mechanism that might contribute to weight gain and type 2 diabetes. [53] [54] [55] Another possibility is that sugar-sweetened beverages are a marker of an unhealthy lifestyle. [56] [57] [58] [59] High consumers of sugar-sweetened beverages consume more energy, take less physical activity and smoke more, [60] [61] [62] all of which may be difficult to measure and adjust for in observational studies.
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Strengths and limitations
The strengths of our study are that we identified all available prospective cohorts through a systematic search strategy, performed quantitative syntheses and conducted an assessment of the quality and strength of the evidence by using the GRADE assessment.
Despite the inclusion of several large, high-quality cohorts, the inability to rule out residual confounding is a limitation inherent in all observational studies, and a reason that observational studies start at low quality by GRADE. Sources of residual confounding include reverse causality, the reliability of self-report intake 64 and measurement of the exposure to sugars, measured and unmeasured confounders included in statistical models, and important collinearity effects from related dietary and lifestyle patterns. Another important limitation is inconsistency between studies. Although the evidence for heterogeneity was partially explained by the removal of several individual studies during sensitivity analyses, residual inconsistency could not be ruled out for total sugars and fructose. A final limitation is the imprecision in the estimates of pooled risk. The 95% CIs were wide and could not rule out clinically important benefit or harm for total sugars and fructose. In addition, there was some instability in the precision of the summary estimates for sucrose.
Balancing the strengths and weaknesses, the evidence was assessed as very low quality for total sugars and fructose, which was based on downgrades for inconsistency and imprecision, and low quality for sucrose, because of the combination of a downgrade for imprecision and an upgrade for an inverse doseresponse gradient. In comparison, the evidence for the association between intake of sugar-sweetened beverages and type 2 diabetes 4,5 would similarly be assessed by GRADE as low quality based on the combination of a downgrade for inconsistency and an upgrade for a positive dose-response gradient.
Conclusion
Our systematic review and meta-analysis of available prospective cohort studies does not support an adverse association between intake of fructose-containing sugars independent of food form and risk of type 2 diabetes. Our confidence in the evidence for this conclusion is generally weak. Sources of uncertainty include the risk of residual confounding in observational studies that prevent causal inferences from being drawn, serious inconsistency between studies and imprecision in estimates of pooled risk for total sugars and fructose, and serious imprecision in estimates of pooled risk for sucrose. Although our observation of a negative dose-response gradient between sucrose and incident diabetes might strengthen our confidence in the lack of harm associated with sucrose, more research is likely to have an important effect on our estimates. In the absence of a clear signal for harm, sugars alone do not appear to explain the relation between sugar-sweetened beverages and type 2 diabetes. More "food-based" research is needed to assess whether the same relation holds for other important food sources of sugars, such as grain and grain-based products, fruit and fruit products, and dairy and dairy products.
